Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 610-672-2 | CAS number: 51503-61-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From 30 October to 18 march 2013
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP study, well conducted on the similar substance Reaction mass of dipotassium phosphonate and Phosphonic acid, potassium salt (1:1). Rationale for Read Across is attached at point 13
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline 487 (in Vitro Mammalian Cell Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
- Reference substance name:
- Potassium Phosphonate KH2PO3/K2HPO3
- IUPAC Name:
- Potassium Phosphonate KH2PO3/K2HPO3
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material: potassium phosphonate KH2PO3/K2HPO3
- Substance type: inorganic
- Physical state: limpid fluid colourless solution
- Storage condition of test material: room temperature
- Stability: no assay of test item stability, nor its concentration and homogeneity in solvent were undertaken
- Expiration date of the lot/batch: 16/12/2013
- Purity: 50%
- Preparation:immediately before use in sterile water of injectable grade on a weight/volume basis, with correction for the displacement due to the volume of the test item. All solutions were used within 25 minutes from the initial formulation. Treatments were performed under safe light conditions when the positive control Colchicine was included.
The solubility of the test item was assess during the test: during the first main experiment, the test item was found to be miscible with sterile distilled water of injectable grade. Following treatment with the test item, no opacity of the medium nor precipitation of the test item was observed at the beginning or end of treatment, both in the absence or presence of S9 metabolism.
The osmolality and the pH were assess during the test.
Following treatment with the test item, no remarkable variation of osmolality and pH was observed in the absence or presence of S9 metabolism in any experiment.
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Source: Dr. J. Thacker, MRC Radiobiology Unit, Harwell, UK
This cell line, V79 4(H) can be traced back directly to the original V79 isolate prepared by Ford and Yerganian (1958). The karyotype, generation time and plating efficiency have been checked. The cells are checked at regular intervals for the absence of mycoplasmal contamination.
- Storage: in liquid nitrogen and subcultures are prepared from the frozen stocks for experimental use
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9
- Test concentrations with justification for top dose:
- S9 time (hours) Dose levels µg/mL.
1 - 3 5000, 2500, 1250, 625 and 313
1 + 3 5000, 2500, 1250, 625 and 313
2 - 24 5000, 3570, 2550, 1820, 1300 and 930
2 + 3 5000, 3570, 2550, 1820, 1300 and 930 - Vehicle / solvent:
- sterile injectable water
Controlsopen allclose all
- Negative solvent / vehicle controls:
- yes
- Remarks:
- sterile injectable water grade
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- other: Colchicine
- Remarks:
- Absence of S9 metabolism
- Negative solvent / vehicle controls:
- yes
- Remarks:
- sterile injectable water grade
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- Presence of S9 metabolism
- Details on test system and experimental conditions:
- S9 TISSUE HOMOGENATE
- Source: Trinova Biochem GmbH (producer: MOLTOX, Molecular Toxicology, Inc., USA)
- Species: rat
- Strain: Sprague Dawley
- Sex: male
- Tissue: liver
- Inducing Agents: Phenobarbital-5,6-Benzoflavone
S9 MIX (15 ml)
S9 tissue fraction, NADP, G-6-P, Hepes buffer, KCl, HBSS Hank's Balanced salt solution
CULTURE MEDIUM
EMEM Minimal medium, EMEM Complete, DMEM Minimal medium, DMEM Complete medium
EXPERIMENTAL DESIGN
- Preliminary toxicity assay;
- Treatment:
ASSAY n.1= without S9, for 3 hours, dose levels (5000-2500-1250-625-313, 156, 78.1, 39.1 µg/mL)
ASSAY n.1= with S9, for 3 hours, dose levels (5000-2500-1250-625-313, 156, 78.1, 39.1 µg/mL)
ASSAY n.2= final concentration of 3 µg/mL, incubated for 26 hours at 37 °C. until harvesting.
Harvesting and slide preparation/evaluation
DEVIATION FROM STUDY PROTOCOL
Procedures were in agreement with the Study Protocol, with the exception of the following deviations:
- for the first main experiment, scoring of binucleated cells and not mononucleated cells was performed for cultures treated with Colchicine.
- due to technical reasons, DMEM complete medium and not EMEM complete medium was used for the first main experiment.
Those deviations were not considered to have affected the integrity or purpose of the study. - Evaluation criteria:
- IDENTIFICATION CRITERIA
- The micronucleus diameter was less than 1/3 of the nucleus diameter;
- The micronucleus diameter was greater than 1/16 of the nucleus diameter;
- No overlapping with the nucleus was observed;
- The aspect was the same as the chromatin;
CRITERION FOR OUTCOME
- Significant increases in the proportion of micronucleated cells over the concurrent controls occur at one or more concentrations;
- The proportion of micronucleated cells at such data points exceeds the normal range. If the increases fall within the range of values normally observed in the negative control cultures, the test item cannot be classified as positive. Any significant increases over the concurrent negative controls were therefore compared with historical control values derived from recent studies;
- There is a significant dose-relationship. - Statistics:
- A modified chi-squared test is used to compare the number of cells bearing micronuclei in control and treated cultures.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- EVALUATION OF RESULTS
Following treatment with the test item, no statistically significant increase in the incidence of micronucleated cells over the negative control value was observed at any dose level in the first main experiment.
In the second main experiment, statistically significant increases in the incidence of micronucleated cells over the concurrent negative control value were observed at the high and intermediate dose levels selected for scoring.
Besides, a dose-effect relationship was indicated and at the highest dose level, incidences exceeded the range of RTC historical values for negative controls in both replicate cultures.
Statistically significant increases in the proportion of micronucleated cells compared with the relevant control values were observed in the cultures treated with the positive controls Cyclophosphamide, Mitomycin-C and Colchicine, indicating the correct functioning of the assay system.
SELECTION OF DOSE LEVELS FOR SCORING
For the first main experiment, following treatment with the test item, no cytotoxicity was observed in the absence or presence of S9 metabolism at any dose level.
For the second main experiments, moderate cytotoxicity (36%) was observed at the highest dose level selected for treatment (4000 µg/mL), mild cytotoxicity was observed at the two lower dose levels of 3330 and 2780 g/mL (22% and 20%, respectively). No cytotoxicity was observed over the remaining dose range.
The highest dose level for genotoxicity assessment is selected as a dose which produces a substantial cytotoxicity compared with the solvent control. Ideally the cytotoxicity should be between 50% and 60%. In the absence of cytotoxicity the highest treatment level is selected as the highest dose level for scoring. Two lower dose levels are also selected for the scoring of micronuclei.
The summary data are shown in table 1 and 2. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1. Summary table of the treatment time 3h, sampling time 27 hours (main assay 1)
Presence of S9 metabolism | Absence of S9 metabolism | ||||||
Treatment | Dose level (mg/mL) | ||||||
%Mn cells | Sig. | %Cytotoxicity | %Mn cells | Sig. | %Cytotoxicity | ||
Untreated | 0.0 | 1.30 | 2 | 0.85 | 3 | ||
Solvent 10% | 0.0 | 0.90 | 0 | 0.70 | 0 | ||
Test item | 1250 | 1.25 | NS | -4 | 0.85 | NS | 2 |
Test item | 2500 | 0.80 | NS | -1 | 0.90 | NS | 5 |
Test item | 5000 | 0.60 | NS | -6 | 0.85 | NS | 1 |
Mitomycin-C | 0.300 | - | - | 4.15 | *** | 12 | |
Colchicine | 2.50 | - | - | 2.50 | *** | -6 | |
Cyclophosphamide | 10.0 | 4.10 | *** | 58 | - | - |
Table 2. Summary table of the treatment time 26h, sampling time 27 hours (main assay 2)
Absence of S9 metabolism | ||||
Treatment | Dose level (mg/mL) | |||
%Mn cells | Sig. | %Cytotoxicity | ||
Untreated | 0.0 | 0.45 | 1 | |
Solvent 10% | 0.0 | 0.55 | 0 | |
Test item | 2780 | 0.90 | NS | 20 |
Test item | 3300 | 1.40 | * | 22 |
Test item | 4000 | 4.50 | *** | 36 |
Mitomycin-C | 0.100 | 6.35 | *** | 32 |
Colchicine | 0.250 | 12.2 | *** | 98 |
%Mn cells: Percentage of cells bearing micronuclei
Sig.: Statistical significance
NS: Not significant
-: Not tested or not selected for scoring
*: Statistically significant at p<0.05
** : Statistically significant at p<0.01
***: Statistically significant at p<0.001
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
positive without metabolic activation
negative with metabolic activation
It can be concluded that Potassium phosphonate – Multicomponent induces micronuclei in Chinese hamster V79 cells after in vitro treatment in the absence of S9 metabolic activation, under the reported experimental conditions. - Executive summary:
Potassium Phosphonate multicomponent (K2HPO3/KH2PO3) was assayed for the ability to induce micronuclei in Chinese hamster V79 cells, following in vitro treatment in the presence and absence of S9 metabolic activation.
Two main experiments were performed.
In the first experiment, the cells were treated for 3 hours in the presence and absence of S9 metabolism, respectively. The harvest time of 27 hours corresponding to approximately 2.0 cell cycle lengths was used.
As negative results were obtained, a second experiment was performed in the absence of S9 metabolism using approximately the same harvest time. A continuous treatment until harvest at 26 hours was used.
For the first main experiment, the maximum dose level for treatment was selected in agreement with the Study Protocol.
Dose levels of 5000, 2500, 1250, 625, 313, 156, 78.1 39.1 µg/mL were used both in the absence and presence of S9 metabolism.
Based on the cytotoxicity observed in the first experiment, dose levels of 4000, 3300, 2780, 2310, 1930, 1610, 1340, 1120, 930 and 775 µg/mL were selected for the second main experiment.
Test item solutions were prepared in sterile water for injection.
Each experiment included appropriate negative and positive controls. Two cell cultures were prepared at each test point. The actin polymerisation inhibitor Cytochalasin-B was added prior to the targeted mitosis to allow the selective analysis of micronucleus frequency in binucleated cells.
Dose levels were selected for the scoring of micronucleated cells on the basis of the cytotoxicity of the test item treatments calculated by thecytokinesis-block proliferation index (CBPI).
In the first experiment, the cells were treated for 3 hours in the presence and absence of S9 metabolism, respectively. The harvest time of 27 hours corresponding to approximately 2.0 cell cycle lengths was used.
As negative results were obtained, a second experiment was performed in the absence of S9 metabolism using approximately the same harvest time. A continuous treatment until harvest at 26 hours was used.
For the first main experiment, the maximum dose level for treatment was selected in agreement with the Study Protocol.
Dose levels of 5000, 2500, 1250, 625, 313, 156, 78.1 39.1 µg/mL were used both in the absence and presence of S9 metabolism.
Based on the cytotoxicity observed in the first experiment, dose levels of 4000, 3300, 2780, 2310, 1930, 1610, 1340, 1120, 930 and 775 µg/mL were selected for the second main experiment.
Test item solutions were prepared in sterile water for injection.
Each experiment included appropriate negative and positive controls. Two cell cultures were prepared at each test point. The actin polymerisation inhibitor Cytochalasin-B was added prior to the targeted mitosis to allow the selective analysis of micronucleus frequency in binucleated cells.
Dose levels were selected for the scoring of micro-nucleated cells on the basis of the cytotoxicity of the test item treatments calculated by thecytokinesis-block proliferation index (CBPI).
S9 Treatment time (hours) Harvest time (hours) Dose level (µg/mL)
1 -/+ 3 27 5000, 2500 and 1250
2 - 26 26 4000, 3300 and 2780
One thousand binucleated cells per culture were scored to assess the frequency of micronucleated cells.
Following treatment with the test item, no statistically significant increase in the incidence of micronucleated cells over the concurrent negative control value was observed at any dose level in the first main experiment.
In the second main experiment, statistically significant increases in the incidence of micronucleated cells over the concurrent negative control value were observed at the high and intermediate dose levels selected for scoring. In addition, a dose-effect relationship was indicated and at the highest dose level, incidences exceeded the range of RTC historical values for negative controls in both replicate cultures.
Statistically significant increases in the incidence of micronucleated cells were observed following treatments with the positive controls Cyclophosphamide, Mitomycin-C and Colchicine, indicating the correct functioning of the test system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.